Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
4m agoConduent Announces Agreement to Sell Its Public Transit Business to Modaxo for $164 Million
6m agoFCPT Announces Acquisition of a Gerber Collision Property for $3.5 Million
9m agoIntegrated Quantum Technologies Announces Refiling of MD&A
9m agoNVent to Participate in Upcoming Investor Conference
9m agoBuzz Capital Inc. Announces Non-Brokered Private Placement
Virax Biolabs Group Limited logo

Virax Biolabs Group Limited

About

0.31USD-0.01 -4.08%
Closed • Updated at 21:50 GMT+00:00
Market Cap$6.10M
Volume11.14M
Beta2.86
RSI74.54
Gross Margin-14976.66%
FinanceFinancial Conglomerates

Virax Biolabs Group Limited — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 31 2026
Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation
Dec 4 2025
Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement
Dec 3 2025
Virax Biolabs Group Limited Announces $5 Million Private Placement
Dec 3 2025
Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders
Nov 3 2025
Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes

Community Chat

Ask AI

6ix6ix